FTC Puts Hospitals on Notice About Price Transparency
Consumer protection attorney Benjamin Genn was interviewed for a Corporate Counsel article about the Federal Trade Commission's (FTC) crackdown on healthcare price transparency. The FTC sent warning letters to 24 of the country's largest healthcare systems cautioning that the price of a medical procedure is a material term under Section 5 of the FTC Act, meaning it needs to be clearly and conspicuously disclosed and that omitting aspects of the total cost such as physician or facility fees could violate the law – even if the initial price includes a disclaimer that the number seen may not be final. This move corresponds to broader efforts around pricing transparency in the healthcare industry, including those initiated by the Centers for Medicare & Medicaid Services (CMS).
Benjamin told Corporate Counsel the letters put the entire sector on notice that the government is watching and multiple agencies stand ready to act. He advised healthcare providers to audit pricing practices, paying special attention to areas where initial quotes do not match the final bill so they can develop a plan to explain the disparity if enforcement authorities come knocking.
"What they're really telling us is they're going to be a secondary enforcer to CMS," he said. "It's really layering their authority on top of CMS' authority."
READ: FTC Puts Hospitals on Notice About Price Transparency (Subscription required)
Benjamin also published a Holland & Knight alert on this topic.